Gen AI in Business - Global Trends Report 2024.pdf
香港六合彩
1. Mechanisms for extending lifespan (SENS): genetic aspects Aubrey D.N.J. de Grey Department of Genetics, University of Cambridge Email: [email_address] uk Reprints, general info: http://www.gen.cam.ac.uk/sens/
2. “ Is he nuts?” http://www.technologyreview.com/articles/05/02/issue/mag_toc.asp
3. Aging in a nutshell Metabolism (the hugely messy network of homeostatic processes that keep us alive) causes Pathology (the hugely messy network of anti-homeostatic processes that kill us) This is not controversial -- indeed, it is why most biogerontologists think there’s little hope of curing aging for ages
5. An oft-neglected observation Aging is indisputably a side-effect of essential biochemical and cellular processes BUT Its functional effect (loss of performance) is delayed Putting it another way: Being alive must have immediate side-effects, since metabolically active molecules are short-lived BUT Those effects must accumulate , and have a threshold level below which they are harmless
6. Aging in slightly less of a nutshell Metabolism ongoingly causes “ damage ” whereas Damage only eventually causes pathology This turns out to be very useful
8. Paradigms for intervention Gerontology Engineering Geriatrics Metabolism Damage Pathology Claim: unlike the others, the engineering approach can achieve a large extension of human healthy lifespaspan quite soon
10. FAQ #1: How do you know that this list is complete?
11. 20 years is a suspiciously long time to find nothing out Harman (1972) Mitochondrial mutations Strehler (1959) or earlier Lysosomal junk Brody (1955) or earlier Cell loss, cell atrophy Hayflick (1965) Cell senescence Alzheimer (1907) Extracellular junk Monnier and Cerami (1981) Extracellular crosslinks Szilard (1959) and Cutler (1982) Nuclear [epi]mutations (only cancer matters) Proposed as contributing to aging by Damage rising with age
12. FAQ #2: OK… How close are we to fixing these things?
13. We know how to fix all of them (in mice, in principle!) See www.gen.cam.ac.uk/sens/ for detail (lots of it, including all my publications) Allotopic expression of 13 proteins Mitochondrial mutations Transgenic microbial hydrolases Lysosomal junk Exercise, cell therapy, growth factors Cell loss, cell atrophy Cell ablation, reprogramming Death-resistant cells Phagocytosis by immune stimulation Extracellular junk AGE-breaking molecules/enzymes Extracellular crosslinks WILT: Telomerase/ALT knockout plus periodic stem cell reseeding Nuclear [epi]mutations (only cancer matters) It or its effects reversible by Damage rising with age
14.
15. SENS components cover the genetic bases ( no pun intended …) Allotopic expression: insert many genes Xenohydrolases: insert foreign genes WILT: target genes, in vitro and in vivo Q: How could these therapies ever undergo clinical trials?!
16. Q: How could these therapies ever undergo clinical trials?! A: Robust Mouse Rejuvenation Definition of RMR: trebling of the remaining lifespan of a cohort of 2yo mice that normally die at 3yo
17.
18. Indefinite youth????!!!! Gerontology Engineering Geriatrics Metabolism Damage Pathology Damage can be kept sub-pathogenic indefinitely by repair that only asymptotically approaches perfection
19. Longevity escape velocity Conclusion: RHR gives LEV . The first 1000-year-old is probably only ~10 years younger than the first 150-year-old
20. RMR’s probable impact on clinical trial policy - Timeframe: I predict RMR will be achieved within 10 years - How achieved: I predict all 7 SENS strands will be necessary for RMR or seen by then to be necessary for RHR - Moreover: not just necessary, but sufficient - Consequence: global “War On Aging”